With the first half of the year officially coming to a close, we can now say that, despite some hiccups during the second quarter and ongoing supply issues throughout Canada and the U.S., pot stocks “kicked some bud.” For instance,…
You’d be hard-pressed right now to find a faster-growing industry than legal cannabis. Between 2018 and 2024, the newest report from Arcview Market Research and BDS Analytics, “State of the Legal Cannabis Markets,” predicts a near quadrupling in worldwide licensed-store…
Marijuana is a smoking hot niche today, with industry watchers providing massive growth projections for demand as the drug’s legal availability increases. The stocks associated with the sector are hot, too. One interesting way to play the space without actually buying a…
According to a newly released report from the duo of Arcview Market Research and BDS Analytics titled “State of the Legal Cannabis Markets,” global cannabis sales could grow in excess of 24% per year through 2024. After registering $10.9 billion…
Canopy Growth (NYSE:CGC) didn’t exactly wow investors with its fiscal 2019 fourth-quarter results last week. The Canadian cannabis producer reported lower quarter-over-quarter cannabis sales on all fronts, although overall revenue increased thanks primarily to its acquisition of German vaporizer device…
If you’re looking to buy a marijuana stock, Aphria (NYSE:APHA) and Canopy Growth (NYSE:CGC) should probably be on your list for consideration. They’re two of the largest Canadian cannabis producers in terms of production capacity. Both Aphria and Canopy Growth…
